Zimmermann Martine
SEC CIK 1994049 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| LGND | LIGAND PHARMACEUTICALS INC | Dir | 3,782 | — | $342.0K | 9 | 2023-09-22 | 2026-09-22 |
Most active insiders at LGND, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Espinoza Octavio | CFO | — | $13.03M |
| 2 | Reardon Andrew | CLO, Sec | — | $8.77M |
| 3 | Haas Jason | Dir | — | $3.74M |
| 4 | LAMATTINA JOHN L | Dir | — | $2.44M |
| 5 | Gray Nancy Ryan | Dir | — | $1.35M |
| 6 | Aryeh Jason | Dir | — | $1.25M |
| 7 | KOZARICH JOHN W | Dir | — | $1.20M |
| 8 | Sabba Stephen L | Dir | — | $1.16M |
| 9 | Zimmermann Martine | Dir | — | $342.0K |
| 10 | Davis Todd C | CEO, Dir | — | — |
Transactions 9
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-24 17:22 | 2026-09-22 | LGND | LIGAND PHARMACEUTICALS INC | Zimmermann Martine | Dir | F - Tax | $298.50 | -115 | 3,782 | -3% | -$34.3K | |
| 2026-09-14 16:59 | 2026-09-10 | LGND | LIGAND PHARMACEUTICALS INC | Zimmermann Martine | Dir | S - Sale | $285.00 | -1,200 | 3,897 | -24% | -$342.0K | |
| D | 2026-06-09 19:42 | 2026-06-05 | LGND | LIGAND PHARMACEUTICALS INC | Zimmermann Martine | Dir | A - Grant | $0.00 | +836 | 5,279 | +19% | $0 |
| D | 2026-06-09 19:42 | 2026-06-05 | LGND | LIGAND PHARMACEUTICALS INC | Zimmermann Martine | Dir | F - Tax | $237.00 | -182 | 5,097 | -3% | -$43.1K |
| 2025-09-24 | 2025-09-22 | LGND | LIGAND PHARMACEUTICALS INC | Zimmermann Martine | Dir | F - Tax | $170.77 | -115 | 4,443 | -3% | -$19.6K | |
| D | 2025-06-10 | 2025-06-06 | LGND | LIGAND PHARMACEUTICALS INC | Zimmermann Martine | Dir | A - Grant | $0.00 | +1,209 | 4,746 | +34% | $0 |
| D | 2025-06-10 | 2025-06-06 | LGND | LIGAND PHARMACEUTICALS INC | Zimmermann Martine | Dir | F - Tax | $105.99 | -188 | 4,558 | -4% | -$19.9K |
| D | 2024-06-18 | 2024-06-14 | LGND | LIGAND PHARMACEUTICALS INC | Zimmermann Martine | Dir | A - Grant | $0.00 | +1,252 | 3,537 | +55% | $0 |
| D | 2023-09-26 | 2023-09-22 | LGND | LIGAND PHARMACEUTICALS INC | Zimmermann Martine | Dir | A - Grant | $0.00 | +2,285 | 2,285 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations